Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Medicago
Medicago
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Design & Build
Medicago contributes CA$500,000 to help establish Class 3 containment laboratory at Université Laval
Remaining two-thirds of the funds will be provided by the City of Quebec and the research centre's foundation
Research & Development
Medicago to develop Ebola monoclonal antibodies for the Canadian government
Plant-based antibodies to be developed in mini-factories to fight the Sudan strain of the Ebola virus
Manufacturing
Medicago to build C$245m vaccine production facility in Quebec City, Canada
Will create 200 new highly skilled jobs by 2019
Finance
Mitsubishi Tanabe Pharma to acquire Medicago for $357m
Medicago has been collaborating with MTPC since 2012 to develop and commercialise rotavirus VLP-based vaccines
Manufacturing
Medicago produces rotavirus VLP vaccine candidate
It comprises all four structural antigens of rotavirus using its plant-based manufacturing platform
Research & Development
Medicago and Mitsubishi to develop next generation technology for plant production
Companies to evaluate closed hydroponic Plant Factory System
Research & Development
Canadian government awards US$493,000 to Medicago
To support development of new potency assays and process analytical technologies
Subscribe now